ApiFix announces new leadership
ApiFix, developers of a minimally invasive non-fusion scoliosis correction system,announced the appointment of Ed Roschak, the former CEO of Ellipse Technologies, as its new chairman. Industry veteran Paul Mraz joins him as company president and CEO.
Ed Roschak served as president and CEO of Ellipse Technologies for five years, when it was acquired by NuVasive, Inc. for US$410 million. Ellipse developed a magnetic growth rod technology for treating early onset scoliosis of the spine and for limb lengthening procedures.
Paul Mraz brings more than 25 years of spine and orthopedic medical device experience to ApiFix. He served as CEO and in other senior executive and management positions in U.S.- and Israel-based companies. Previously, he was managing partner of business strategy and leadership consulting firm OnPoint Advisors, which he founded in 2013. From 2006 to 2013, Mraz served as president and CEO of medical device and biologics company Cerapedics, which developed and is now commercializing biologic bone grafting products for the spine and orthopedic markets.
Todd Dollinger, CEO and chairman of Trendlines and outgoing ApiFix chairman, commented, “We believe the deep experiences Ed and Paul bring make them ideal to take ApiFix to the next level, and we are excited to welcome them on board. Trendlines is extremely proud of ApiFix’s achievements to date and we’re confident that the combined efforts of Ed and Paul will be instrumental in realizing ApiFix’s strategic focus on the U.S. and European markets as the company finalizes its application for FDA clearance.”
Dollinger cited Roschak’s substantial work in every aspect of building a scoliosis treatment company as key reasons ApiFix sought to bring him in as chairman of the ApiFix board. Similarly, Mraz has extensive leadership experience bringing innovative spine technologies to market for the benefit of patients and all stakeholders. With ApiFix’s U.S. market entry plans in process, the new CEO will establish ApiFix’s U.S. headquarters in the Boston area. R&D and manufacturing activities will remain in Israel under the leadership of Uri Arnin, ApiFix co-founder and CTO.
The ApiFix system is a disruptive platform technology with its less invasive, non-fusion scoliosis correction system implanted in a short procedure that maintains spine flexibility and requires a brief recovery period.